切换导航
关于我们
关于我们
Our Mission
发展历程
Global Footprint
公司团队
董事会
科学与技术
研发管线
战略合作
投资者与媒体
加入我们
EN
中文
首页
>
研发管线
研发管线
多元化管线
Integrated, scalable, proprietary manufacturing platform
Unique mechanisms of action
Small production footprint to produce billions of doses of vaccines
Rapidly adapted to address new variants of concern
Long shelf life at 2- 8 °C
管线
Target/MoA
Discovery
Pre-Clinical
Phase 1/2
Phase 3
Commercial
Oncology
JCXH-211
( srRNA )
IL-12
JCXH-211
( srRNA )
IL-12
Cancer Vaccines
JCXH-212
( srRNA )
Cancer Vaccine
JCXH-212
( srRNA )
Cancer Vaccine
Cytokines
TBD
( Undisclosed )
Antibodies
TBD
( Undisclosed )
Antibodies
In vivo CAR
Infectious Diseases
JCXH-221
(mRNA)
Vaccine
JCXH-221
(mRNA)
Vaccine
Broadly protective COVID
JCXH-105
( srRNA )
Vaccine
JCXH-105
( srRNA )
Vaccine
Shingles
JCXH-107
( mRNA )
Vaccine
JCXH-107
( mRNA )
Vaccine
Seasonal quadri/trivalent influenza
JCXH-108
(mRNA)
Vaccine
JCXH-108
(mRNA)
Vaccine
RSV
TBD
( mRNA )
Vaccine
TBD
( mRNA )
Vaccine
Flu/COVID combo
TBD
( srRNA )
Vaccine
TBD
( srRNA )
Vaccine
HSV-2
Rare Diseases
JCXH-301
( mRNA )
Enzyme Replacement
JCXH-301
( mRNA )
Enzyme Replacement
Gaucher’s Disease
Medical Cosmetology
JCXH-G
( mRNA )
Undisclosed
JCXH-G
( mRNA )
Undisclosed
Therapeutic acnes vaccine